Wednesday Mar 12
Largest Microbiome Study on Newly Diagnosed Patients Gives Insight...
An important new study funded by the Crohn's & Colitis Foundation of America and published in the March 12 issue of Cell Host & Microbe , reveals several important findings that identify the microbiome in early-onset Crohn's disease and highlight particular microbes that are increased or decreased in abundance in the disease.
Trending on the Topix Network
Wednesday Mar 12
Risk Factors for Depression after IBD diagnosis
Register today to receive your daily dose of health news. Get the latest information delivered to your inbox with our free dailyRx Newsletter! Connect with the dailyRx social media channels to receive the latest health news and information and to stay up to date on dailyRx promotions! Stay up to date with the health news that matters most! Choose ... (more)
Wednesday Mar 12
Bertilimumab Is A Potential Blockbuster Drug For Immune Pharma
We have decided to take an in-depth look at bertilimumab, the leading pipeline candidate at Immune Pharmaceuticals .
Tue Mar 11, 2014
Anti-tumor necrosis factor-alpha agents for the treatment of ulcerative colitis
The latest issue of the Alimentary Pharmacology & Therapeutics reviews the efficacy of anti-tumor necrosis factor-alpha agents for the treatment of ulcerative colitis.
Use of confocal laser endomicroscopy to predict relapse of ulcerative colitis
Assessment of inflammatory activity in patients with ulcerative colitis is crucial to the prediction of relapse.
The Jersey Journal
NJ jury orders drugmaker Roche to pay $1.5M at Accutane trial
A New Jersey jury today found drugmaker Roche failed to properly warn Kamie Kendall's doctors that acne medicine Accutane could cause ulcerative colitis and were liable for her injuries.
Mon Mar 10, 2014
Declining risk of colorectal cancer in ulcerative colitis
Dr Castano-Milla and colleagues from Spain assessed the risk of colorectal cancer in ulcerative colitis patients by systematic review and meta-analysis.
Sun Mar 09, 2014
East-West gradient in the incidence of IBD in Europe
Dr Burisch and colleagues from Denmark investigated whether an EastA-West gradient in the incidence of IBD in Europe exists.
Tue Mar 04, 2014
Featured in NEJM Journal Watch: Infliximab and Azathioprine Combined for Ulcerative Colitis
Corticosteroid-free remission after 16 weeks was higher with combination therapy than with either drug alone in a study published in Gastroenterology .
Sun Mar 02, 2014
Tiny light helps save lives
A tiny ray of light is making a big difference against two deadly autoimmune diseases, like Chron's and Ulcerative Colitis.
Thu Feb 27, 2014
Genesee Country Express
Physician Focus: Living with Crohn's and colitis
Crohn's disease and ulcerative colitis are digestive disorders that are types of inflammatory bowel disease.
Wed Feb 26, 2014
Harrogate mum's battle to beat colitis for good
A Harrogate mum is training hard to take on the Great North Run - in a bid to beat chronic disease Ulcerative Colitis for good.
Healing by faeces: Rise of the DIY gut-bug swap
LAST year wasn't kind to 27-year-old Jim. He was diagnosed with ulcerative colitis and it was causing him a lot of pain.
Applied Clinical Trials
Altheus Therapeutics completes treatment portion of ZA201, a Phase 2...
The primary endpoint of ZA201 is reduction in the Ulcerative Colitis Disease Activity Index at 6 weeks.
Tue Feb 25, 2014
Recent Developments Do Not Justify Athersys' Doubling Since December
Since early December, Athersys, Inc. is up more than 100%, with the company doubling in value from a little over $120M to its current capitalization of $240M.
InDex Pharmaceuticals AB Closes $20 Million Financing Round, Welcomes As New Shareholder
Stockholm/Sweden, February 25, 2014 - InDex Pharmaceuticals today announced the successful closing of a USD 20 million / EUR 15 million new rights issue.
Mon Feb 24, 2014
Cosmo announces results of share buyback through public tender offer
The offer period lasted from The number of tendered shares accepted for repurchase will be reduced proportionally, i.e. acceptance is at a factor of 93.797% of tendered shares.
Job strain and the risk of inflammatory bowel diseases:...
Many clinicians, patients and patient advocacy groups believe stress to have a causal role in inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis.
Sun Feb 23, 2014
Novel use of melatonin in ulcerative colitis
The latest issue of the Inflammatory Bowel Diseases identifies various molecular targets for melatonin with the intent of providing novel strategies for combating ulcerative colitis.
New Market Research Report: InDex Pharmaceuticals AB -...
It develops two products from its proprietary technology platform. Its products include Kappaproct, which is in Phase III clinical trials for the treatment of refractory ulcerative colitis; and DIMS 9054, a development candidate for treatment of resistant pulmonary inflammation.